Regulatory B cells in autoimmune diseases and mucosal immune homeostasis

References

• Katz SI, Parker D, Turk JL. B-cell suppression of delayed hypersensitivity reactions. Nature. 1974; 251 5475: 550.
   PubMed Web of Science ®Google Scholar
• Bouaziz J-D, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev. 2008; 224 1: 201–214.
   Google Scholar
• Fillatreau S, Gray D, Anderton SM. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol. 2008; 8 5: 391.
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol. 2006; 176 2: 705–710.
   PubMed Web of Science ®Google Scholar
• Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977; 146 3: 857–868.
   PubMed Web of Science ®Google Scholar
• Korganow A-S, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali J-L, Benoist C, Mathis D. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity. 1999; 10 4: 451.
   PubMed Web of Science ®Google Scholar
• Yanaba K, Hamaguchi Y, Venturi GM, Steeber DA, St. Clair EW, Tedder TF. B cell depletion delays collagen-induced arthritis in mice: Arthritis induction requires synergy between humoral and cell-mediated immunity. J Immunol. 2007; 179 2: 1369–1380.
   Google Scholar
• Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003; 197 4: 489–501.
   PubMed Web of Science ®Google Scholar
• Evans JG, Chavez-Rueda KV, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, Ehrenstein MR, Mauri C. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol. 2007; 178 12: 7868–7878.
   PubMed Web of Science ®Google Scholar
• Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA. 2007; 104 35: 14080–14085.
   PubMed Web of Science ®Google Scholar
• Mauro CDC, Roger WM, Byung SK, Stephen DM. Two models of multiple sclerosis: Experimental allergic encephalomyelitis (EAE) and theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc Res Tech. 1995; 32 3: 215–229.
   Google Scholar
• Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH, HERMES Trial Group. B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. 2008; 358 7: 676–688.
   PubMed Web of Science ®Google Scholar
• Wolf SD, Dittel BN, Hardardottir F, Janeway CAJr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med. 1996; 184 6: 2271–2278.
   PubMed Web of Science ®Google Scholar
• Gonnella PA, Waldner HP, Weiner HL. B cell-deficient ({micro}MT) mice have alterations in the cytokine microenvironment of the gut-associated lymphoid tissue (GALT) and a defect in the low dose mechanism of oral tolerance. J Immunol. 2001; 166 7: 4456–4464.
   Google Scholar
• Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002; 3 10: 944.
   PubMed Web of Science ®Google Scholar
• Matsushita T, Yanaba K, Bouaziz J-D, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008; 118 10: 3420.
   PubMed Web of Science ®Google Scholar
• Anderson MS, Bluestone JA. The NOD mouse: A model of immune dysregulation. Ann Rev Immunol. 2005; 23 1: 447–485.
   Google Scholar
• Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol. 2001; 167 2: 1081–1089.
   PubMed Web of Science ®Google Scholar
• Hussain S, Delovitch TL. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J Immunol. 2007; 179 11: 7225–7232.
   Google Scholar
• Pettersson I, Hinterberger M, Mimori T, Gottlieb E, Steitz JA. The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem. 1984; 259 9: 5907–5914.
   Google Scholar
• Fatenejad S, Brooks W, Schwartz A, Craft J. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp- lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target. J Immunol. 1994; 152 11: 5523–5531.
   Google Scholar
• Yan J, Mamula MJ. B and T cell tolerance and autoimmunity in autoantibody transgenic mice. Int Immunol. 2002; 14 8: 963–971.
   Google Scholar
• Amano H, Amano E, Moll T, Marinkovic D, Ibnou-Zekri N, Martinez-Soria E, Semac I, Wirth T, Nitschke L, Izui S. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J Immunol. 2003; 170 5: 2293–2301.
   Google Scholar
• Lenert P, Brummel R, Field EH, Ashman RF. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol. 2005; 25 1: 29.
   PubMed Web of Science ®Google Scholar
• Brummel R, Lenert P. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J Immunol. 2005; 174 4: 2429–2434.
   Google Scholar
• Madan R, Demircik F, Surianarayanan S, Allen JL, Divanovic S, Trompette A, Yogev N, Gu Y, Khodoun M, Hildeman D, Boespflug N, Fogolin MB, Grobe L, Greweling M, Finkelman FD, Cardin R, Mohrs M, Muller W, Waisman A, Roers A, Karp CL. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol. 2009; 183 4: 2312–2320.
   PubMedGoogle Scholar
• Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund FE. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000; 1 6: 475.
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 2002; 16 2: 219.
   PubMed Web of Science ®Google Scholar
• Spencer NF, Daynes RA. IL-12 directly stimulates expression of IL-10 by CD5+ B cells and IL-6 by both CD5+ and CD5 − B cells: Possible involvement in age-associated cytokine dysregulation. Int Immunol. 1997; 9 5: 745–754.
   Google Scholar
• Booth JS, Griebel PJ, Babiuk LA, Mutwiri GK. A novel regulatory B-cell population in sheep Peyer's patches spontaneously secretes IL-10 and downregulates TLR9-induced IFN{alpha} responses. Mucosal Immunol. 2009; 2 3: 265.
   Google Scholar
• Matsushita T, Fujimoto M, Hasegawa M, Komura K, Takehara K, Tedder TF, Sato S. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am J Pathol. 2006; 168 3: 812–821.
   Google Scholar
• Watanabe R, Fujimoto M, Ishiura N, Kuwano Y, Nakashima H, Yazawa N, Okochi H, Sato S, Tedder TF, Tamaki K. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol. 2007; 171 2: 560–570.
   Google Scholar
• Yanaba K, Bouaziz J-D, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008; 28 5: 639.
   PubMed Web of Science ®Google Scholar
• Riegert A, Bar-Or A. B-cell-derived interleukin-10 in autoimmune disease: Regulating the regulators. Nat Rev Immunol. 2008; 8 6: 486.
   Google Scholar
• Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, Moser M. B lymphocytes regulate dendritic cell (DC) function in vivo: Increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med. 2000; 192 4: 475–482.
   PubMed Web of Science ®Google Scholar
• Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol. 2000; 12 5: 597–605.
   PubMed Web of Science ®Google Scholar
• Takenoshita S, Fukushima T, Kumamoto K, Iwadate M. The role of TGF-β in digestive organ disease. J Gastroenterol. 2002; 37 12: 991.
   Google Scholar
• Parekh VV, Prasad DVR, Banerjee PP, Joshi BN, Kumar A, Mishra GC. B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: Role of TGF-{beta}1. J Immunol. 2003; 170 12: 5897–5911.
   PubMed Web of Science ®Google Scholar
• Deshpande SP, Zheng M, Daheshia M, Rouse BT. Pathogenesis of Herpes Simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice. J Virol. 2000; 74 8: 3517–3524.
   Google Scholar
• Kang H, Remington JS, Suzuki Y. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-{gamma}, TNF-{alpha}, and inducible nitric oxide synthase. J Immunol. 2000; 164 5: 2629–2634.
   PubMed Web of Science ®Google Scholar
• Smelt SC, Cotterell SEJ, Engwerda CR, Kaye PM. B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. J Immunol. 2000; 164 7: 3681–3688.
   Google Scholar
• Buendia AJ, Del Rio L, Ortega N, Sanchez J, Gallego MC, Caro MR, Navarro JA, Cuello F, Salinas J. B-cell-deficient mice show an exacerbated inflammatory response in a model of Chlamydophila abortus infection. Infect Immun. 2002; 70 12: 6911–6918.
   Google Scholar
• Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol. 2003; 77 4: 2578–2586.
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK. Suppressive role of B cells in chronic colitis of T cell receptor {alpha} mutant mice. J Exp Med. 1997; 186 10: 1749–1756.
   PubMed Web of Science ®Google Scholar
• Kalergis AM, Ravetch JV. Inducing tumor immunity through the selective engagement of activating Fc {gamma} receptors on dendritic cells. J Exp Med. 2002; 195 12: 1653–1659.
   PubMed Web of Science ®Google Scholar
• Legge KL, Gregg RK, Maldonado-Lopez R, Li L, Caprio JC, Moser M, Zaghouani H. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J Exp Med. 2002; 196 2: 217–227.
   PubMed Web of Science ®Google Scholar
• Siragam V, Brinc D, Crow AR, Song S, Freedman J, Lazarus AH. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?. J Clin Invest. 2005; 115 1: 155.
   PubMed Web of Science ®Google Scholar
• Casadevall A, Pirofski L-A. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol. 2003; 24 9: 474.
   Google Scholar
• Brigl M, Brenner MB. CD1: Antigen presentation and T cell function. Ann Rev Immunol. 2004; 22 1: 817–890.
   Google Scholar
• MacDonald HR. NK1.1+ T cell receptor-alpha/beta+ cells: New clues to their origin, specificity, and function. J Exp Med. 1995; 182 3: 633–638.
   Google Scholar
• Schofield L, McConville MJ, Hansen D, Campbell AS, Fraser-Reid B, Grusby MJ, Tachado SD. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science. 1999; 283 5399: 225–229.
   PubMed Web of Science ®Google Scholar
• Chiu Y-H, Park S-H, Benlagha K, Forestier C, Jayawardena-Wolf J, Savage PB, Teyton L, Bendelac A. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat Immunol. 2002; 3 1: 55.
   Google Scholar
• Zhou D, Mattner J, Cantu CIII, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu Y-P, Yamashita T, Teneberg S, Wang D, Proia RL, Levery SB, Savage PB, Teyton L, Bendelac A. Lysosomal glycosphingolipid recognition by NKT cells. Science. 2004; 306 5702: 1786–1789.
   PubMed Web of Science ®Google Scholar
• Kinjo Y, Wu D, Kim G, Xing G-W, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong C-H, Kronenberg M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 2005; 434 7032: 520.
   PubMed Web of Science ®Google Scholar
• Mattner J, DeBord KL, Ismail N, Goff RD, Cantu C, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature. 2005; 434 7032: 525.
   PubMedGoogle Scholar
• Borg NA, Wun KS, Kjer-Nielsen L, Wilce MCJ, Pellicci DG, Koh R, Besra GS, Bharadwaj M, Godfrey DI, McCluskey J, Rossjohn J. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature. 2007; 448 7149: 44.
   Google Scholar
• Koh-Hei S, Joan S-S. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J Immunol. 2002; 32 3: 848–857.
   Google Scholar
• Miley MJ, Truscott SM, Yu YYL, Gilfillan S, Fremont DH, Hansen TH, Lybarger L. Biochemical features of the MHC-related protein 1 consistent with an immunological function. J Immunol. 2003; 170 12: 6090–6098.
   Google Scholar
• Parra-Cuadrado J, del Moral M, García-Pavía P, Setién F, Martínez-Naves E. Characterization of the MHC class I-related MR1 locus in nonhuman primates. Immunogenetics. 2001; 53 8: 643.
   Google Scholar
• Riegert P, Wanner V, Bahram S. Genomics, isoforms, expression, and phylogeny of the MHC class I-related MR1 gene. J Immunol. 1998; 161 8: 4066–4077.
   Google Scholar
• Hansen TH, Huang S, Arnold PL, Fremont DH. Patterns of nonclassical MHC antigen presentation. Nat Immunol. 2007; 8 6: 563.
   Google Scholar
• Schümann J, De Libero G. MR1-restricted Valpha19i T cells - a second population recognizing lipid antigens?. Eur J Immunol. 2007; 37 7: 1724–1726.
   Google Scholar
• Shimamura M, Huang Y-Y, Okamoto N, Suzuki N, Yasuoka J, Morita K, Nishiyama A, Amano Y, Mishina T. Modulation of Valpha19 NKT cell immune responses by alpha-mannosyl ceramide derivatives consisting of a series of modified sphingosines. Eur J Immunol. 2007; 37 7: 1836–1844.
   Google Scholar
• Kawachi I, Maldonado J, Strader C, Gilfillan S. MR1-Restricted V{alpha}19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J Immunol. 2006; 176 3: 1618–1627.
   Google Scholar
• Middendorp S, Nieuwenhuis EES. NKT cells in mucosal immunity. Mucosal Immunol. 2009; 2 5: 393.
   Google Scholar
• Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F, Affaticati P, Gilfillan S, Lantz O. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. 2003; 422 6928: 164.
   PubMed Web of Science ®Google Scholar
• Illes Z, Shimamura M, Newcombe J, Oka N, Yamamura T. Accumulation of V{alpha}7.2-J{alpha}33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int Immunol. 2004; 6 2: 223–230.
   Google Scholar
• Nell LJ, Kastner DL, Rich RR. Qa-1-associated antigens. III. Distribution of Qa-1 region antigens on lymphoid subpopulations. J Immunol. 1980; 125 6: 2597–2603.
   Google Scholar
• Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol. 2004; 5 5: 516–523.
   Google Scholar
• Jiang H, Braunstein NS, Yu B, Winchester R, Chess L. CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice. Proc Natl Acad Sci USA. 2001; 98 11: 6301–6306.
   Google Scholar
• Wei B, Su TT, Dalwadi H, Stephan RP, Fujiwara D, Huang TT, Brewer S, Chen L, Arditi M, Borneman J, Rawlings DJ, Braun J. Resident enteric microbiota and CD8+T cells shape the abundance of marginal zone B cells. Eur J Immunol. 2008; 38 12: 3411–3425.
   PubMed Web of Science ®Google Scholar
• Fujiwara D, Wei B, Presley LL, Brewer S, McPherson M, Lewinski MA, Borneman J, Braun J. Systemic control of plasmacytoid dendritic cells by CD8+T cells and commensal microbiota. J Immunol. 2008; 180 9: 5843–5852.
   Google Scholar
• Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Ann Rev Immunol. 1998; 16 1: 111–135.
   Google Scholar
• Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ. CD40/CD154 interactions at the interface of tolerance and immunity. Ann Rev Immunol. 2004; 22 1: 307–328.
   PubMedGoogle Scholar
• Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest. 1996; 97 9: 2063.
   PubMed Web of Science ®Google Scholar
• Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, Bendelac A, Bach J-F, Monteiro RC. Overexpression of natural killer T cells protects V{alpha}14-J{alpha}281 transgenic nonobese diabetic mice against diabetes. J Exp Med. 1998; 188 10: 1831–1839.
   Google Scholar
• Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature. 2001; 413 6855: 531.
   PubMed Web of Science ®Google Scholar
• Croxford JL, Miyake S, Huang Y-Y, Shimamura M, Yamamura T. Invariant Valpha19i T cells regulate autoimmune inflammation. Nat Immunol. 2006; 7 9: 987.
   Google Scholar
• Hornquist CE, Lu X, Rogers-Fani PM, Rudolph U, Shappell S, Birnbaumer L, Harriman GR. G{alpha}i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. J Immunol. 1997; 158 3: 1068–1077.
   Google Scholar
• Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Boulay G, Bradley A, Birnbaumer L. Ulcerative colitis and adenocarcinoma of the colon in G{alpha}i2-deficient mice. Nat Genet. 1995; 10 2: 143.
   Google Scholar
• Wei B, McPherson M, Turovskaya O, Velazquez P, Fujiwara D, Brewer S, Braun J. Integration of B cells and CD8+T in the protective regulation of systemic epithelial inflammation. Clin Immunol. 2008; 127 3: 303.
   Google Scholar
• Dalwadi H, Wei B, Schrage M, Spicher K, Su TT, Birnbaumer L, Rawlings DJ, Braun J. B cell developmental requirement for the G{alpha}i2 gene. J Immunol. 2003; 170 4: 1707–1715.
   Google Scholar
• Wei B, Velazquez P, Turovskaya O, Spricher K, Aranda R, Kronenberg M, Birnbaumer L, Braun J. Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci USA. 2005; 102 62015.
   Google Scholar
• McPherson M, Wei B, Turovskaya O, Fujiwara D, Brewer S, Braun J. Colitis immunoregulation by CD8+ T cell requires T cell cytotoxicity and B cell peptide antigen presentation. Am J Physiol Gastrointest Liver Physiol. 2008; 295 3: G485–G492.
   Google Scholar
• Izcue A, Coombes J, Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev. 2006; 212 1: 256–271.
   PubMedGoogle Scholar
• Ken S, Atsuhiro O, Yasuyo S, Kiyotaka N, Atsushi M, Atul KB. Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation. Gastroenterology. 2007; 133 1: 124.
   Google Scholar
• Matthieu A, Jens B, Iris D, Lloyd M. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology. 2002; 123 5: 1516.
   Google Scholar
• Lilani P, Ling S, Anjlee P, Kelly E, Bertrand M, Richard B, Daniel G, Veronika G, Thomas S, Bana J, Lloyd M. Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm Bowel Dis. 2007; 13 3: 298–307.
   Google Scholar
• Malin B, Paul WB, Roger W, Hultgren HE. Long-term treatment with anti-&agr;4 integrin antibodies aggravates colitis in G{alpha}i2-deficient mice. Eur J Immunol. 2005; 35 8: 2274–2283.
   Google Scholar